| Human listeriosis caused by Listeria ivanovii C Guillet, O Join-Lambert, A Le Monnier, A Leclercq, F Mechaï, ... Emerging infectious diseases 16 (1), 136, 2010 | 396 | 2010 |
| Regulation of Listeria virulence: PrfA master and commander A de las Heras, RJ Cain, MK Bielecka, JA Vazquez-Boland Current opinion in microbiology 14 (2), 118-127, 2011 | 371 | 2011 |
| The extracellular matrix regulates granuloma necrosis in tuberculosis B Al Shammari, T Shiomi, L Tezera, MK Bielecka, V Workman, ... The Journal of infectious diseases 212 (3), 463-473, 2015 | 130 | 2015 |
| Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α LB Tezera, MK Bielecka, P Ogongo, NF Walker, M Ellis, ... Elife 9, e52668, 2020 | 109 | 2020 |
| Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model LB Tezera, MK Bielecka, A Chancellor, MT Reichmann, BA Shammari, ... Elife 6, e21283, 2017 | 90 | 2017 |
| A bioengineered three-dimensional cell culture platform integrated with microfluidics to address antimicrobial resistance in tuberculosis MK Bielecka, LB Tezera, R Zmijan, F Drobniewski, X Zhang, ... MBio 8 (1), e02073-16, 2017 | 58 | 2017 |
| Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology PT Brace, LB Tezera, MK Bielecka, T Mellows, D Garay, S Tian, L Rand, ... PLoS Pathogens 13 (6), e1006367, 2017 | 55 | 2017 |
| Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis DJ Garay-Baquero, CH White, NF Walker, M Tebruegge, HF Schiff, ... JCI insight 5 (18), 2020 | 49 | 2020 |
| Allosteric mutants show that PrfA activation is dispensable for vacuole escape but required for efficient spread and Listeria survival in vivo C Deshayes, MK Bielecka, RJ Cain, M Scortti, A De las Heras, Z Pietras, ... Molecular microbiology 85 (3), 461-477, 2012 | 38 | 2012 |
| Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins MV Humbert, HL Almonacid Mendoza, AC Jackson, MC Hung, ... Expert review of vaccines 14 (12), 1633-1649, 2015 | 25 | 2015 |
| Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing … MK Bielecka, N Devos, M Gilbert, MC Hung, V Weynants, JE Heckels, ... Infection and Immunity 83 (2), 730-742, 2015 | 24 | 2015 |
| Shigella induces epigenetic reprogramming of zebrafish neutrophils MC Gomes, D Brokatzky, MK Bielecka, FC Wardle, S Mostowy Science advances 9 (36), eadf9706, 2023 | 18 | 2023 |
| Bioelectrospray Methodology for Dissection of the Host-pathogen Interaction in Human Tuberculosis LB Tezera, MK Bielecka, PT Elkington Bio-protocol 7 (14), e2418, 2017 | 13 | 2017 |
| Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis R Phillips, JN Williams, WM Tan, MK Bielecka, H Thompson, MC Hung, ... Vaccine 31 (22), 2584-2590, 2013 | 13 | 2013 |
| Septins promote caspase activity and coordinate mitochondrial apoptosis H Van Ngo, S Robertin, D Brokatzky, MK Bielecka, D Lobato‐Márquez, ... Cytoskeleton 80 (7-8), 254-265, 2023 | 12 | 2023 |
| Advanced cellular systems to study tuberculosis treatment MK Bielecka, P Elkington Current Opinion in Pharmacology 42, 16-21, 2018 | 9 | 2018 |
| Zebrafish null mutants of Sept6 and Sept15 are viable but more susceptible to Shigella infection V Torraca, MK Bielecka, MC Gomes, D Brokatzky, EM Busch‐Nentwich, ... Cytoskeleton 80 (7-8), 266-274, 2023 | 5 | 2023 |
| Exploration into the virulence mechanisms of Listeria MK Bielecka The University of Edinburgh, 2011 | 2 | 2011 |
| Analysis of a cyanobacterial bloom by Matrix-assisted laser desorption/ionisation time of flight mass spectrometry T McKenna, M Willetts, J Batchelor, M Bielecka, G Morton American Society for Mass Spectrometry. Orlando, USA, 2002 | 2 | 2002 |
| Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis X Gonzalo, MK Bielecka, L Tezera, P Elkington, F Drobniewski Antibiotics 11 (10), 1274, 2022 | 1 | 2022 |